3-35681854-G-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_001385562.1(ARPP21):c.103G>T(p.Asp35Tyr) variant causes a missense change. The variant allele was found at a frequency of 0.00000137 in 1,460,190 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000014 ( 0 hom. )
Consequence
ARPP21
NM_001385562.1 missense
NM_001385562.1 missense
Scores
5
7
7
Clinical Significance
Conservation
PhyloP100: 6.88
Genes affected
ARPP21 (HGNC:16968): (cAMP regulated phosphoprotein 21) This gene encodes a cAMP-regulated phosphoprotein. The encoded protein is enriched in the caudate nucleus and cerebellar cortex. A similar protein in mouse may be involved in regulating the effects of dopamine in the basal ganglia. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Jun 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ARPP21 | NM_001385562.1 | c.103G>T | p.Asp35Tyr | missense_variant | 3/21 | ENST00000684406.1 | NP_001372491.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ARPP21 | ENST00000684406.1 | c.103G>T | p.Asp35Tyr | missense_variant | 3/21 | NM_001385562.1 | ENSP00000506922 | P4 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD3 exomes AF: 0.00000400 AC: 1AN: 250164Hom.: 0 AF XY: 0.00000740 AC XY: 1AN XY: 135194
GnomAD3 exomes
AF:
AC:
1
AN:
250164
Hom.:
AF XY:
AC XY:
1
AN XY:
135194
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1460190Hom.: 0 Cov.: 30 AF XY: 0.00000275 AC XY: 2AN XY: 726402
GnomAD4 exome
AF:
AC:
2
AN:
1460190
Hom.:
Cov.:
30
AF XY:
AC XY:
2
AN XY:
726402
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 22, 2023 | The c.103G>T (p.D35Y) alteration is located in exon 3 (coding exon 1) of the ARPP21 gene. This alteration results from a G to T substitution at nucleotide position 103, causing the aspartic acid (D) at amino acid position 35 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Uncertain
T
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
T;.;.;.;T;.;T;.;.;.;.;.;.;T;T;.;.;.;.;.
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;.;D;D;D;D;D;D;.;.;.;.;.;D;D;D;.;.;.;D
M_CAP
Benign
T
MetaRNN
Uncertain
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
.;M;M;.;M;.;.;.;M;M;M;M;M;.;.;M;M;M;M;M
MutationTaster
Benign
D;D;D;D;D;D;D;D;D;D;D;D;D;D;D
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D
REVEL
Benign
Sift
Uncertain
D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D
Sift4G
Pathogenic
D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D
Polyphen
1.0
.;.;D;.;D;.;.;.;.;.;.;.;.;.;.;D;.;.;.;.
Vest4
0.37, 0.27, 0.28, 0.30, 0.35, 0.36
MutPred
Gain of glycosylation at S33 (P = 0.0014);Gain of glycosylation at S33 (P = 0.0014);Gain of glycosylation at S33 (P = 0.0014);Gain of glycosylation at S33 (P = 0.0014);Gain of glycosylation at S33 (P = 0.0014);Gain of glycosylation at S33 (P = 0.0014);Gain of glycosylation at S33 (P = 0.0014);Gain of glycosylation at S33 (P = 0.0014);Gain of glycosylation at S33 (P = 0.0014);Gain of glycosylation at S33 (P = 0.0014);Gain of glycosylation at S33 (P = 0.0014);Gain of glycosylation at S33 (P = 0.0014);Gain of glycosylation at S33 (P = 0.0014);Gain of glycosylation at S33 (P = 0.0014);Gain of glycosylation at S33 (P = 0.0014);Gain of glycosylation at S33 (P = 0.0014);Gain of glycosylation at S33 (P = 0.0014);Gain of glycosylation at S33 (P = 0.0014);Gain of glycosylation at S33 (P = 0.0014);Gain of glycosylation at S33 (P = 0.0014);
MVP
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at